Linc'well vs Ocugine Platform: Revenue, Funding & Team Size Compared
Linc'well generates $1.7M in revenue; Ocugine Platform generates $1.7M. Ocugine Platform and Linc'well are close to the same size by revenue. The table below compares Linc'well and Ocugine Platform on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $1.7M | $1.7M |
| Valuation | $13.3M | Not disclosed |
| Team size | 4 | 28 |
| Founded | 2018 | 2019 |
| HQ | Tokyo, Japan | New York, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Linc'well at a glance
Linc'well generates $1.7M in revenue with 4 employees, headquartered in Tokyo, Japan.
- Revenue
- $1.7M
- Valuation
- $13.3M
- Team size
- 4
- Founded
- 2018
Operator and developer of a technology-enabled clinic chain and SaaS-based platform designed to improve the quality of primary care clinic services In Japan. The company's platform provides web inquiry, call, payment, electronic medical…
Ocugine Platform at a glance
Ocugine Platform generates $1.7M in revenue with 28 employees, headquartered in New York, United States.
- Revenue
- $1.7M
- Team size
- 28
- Founded
- 2019
SaaS platform for game developers. Cloud-Based cross-platform backend set of modules and tools inspired by game developers.
Other Linc'well alternatives
Linc'well competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Linc'well vs Ocugine Platform: frequently asked questions
Is Linc'well or Ocugine Platform bigger?
Ocugine Platform is the bigger company by revenue, at $1.7M against $1.7M for Linc'well.
How much revenue does Linc'well make?
Linc'well generates $1.7M in annual revenue with a team of 4.
How much revenue does Ocugine Platform make?
Ocugine Platform generates $1.7M in annual revenue with a team of 28.